Status:

COMPLETED

Coronary Drug Project Mortality Surveillance

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Coronary Disease

Eligibility:

MALE

30-64 years

Phase:

NA

Brief Summary

To determine whether there were any long term sequelae of the drugs used in the Coronary Drug Project (estrogens, dextrothyroxine, nicotinic acid, clofibrate).

Detailed Description

BACKGROUND: Three of the CDP treatments (two doses of estrogen and dextrothyroxine) were stopped prematurely because of toxicity. At the time the treatments were stopped, it was thought that future a...

Eligibility Criteria

No eligibility criteria

Key Trial Info

Start Date :

June 1 1981

Trial Type :

INTERVENTIONAL

End Date :

March 1 1985

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00000483

Start Date

June 1 1981

End Date

March 1 1985

Last Update

November 26 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.